<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.cmjournal.org/feeds/latestarticles/journal?quantity=&amp;format=rss&amp;version=">
        <title>Chinese Medicine - Latest Articles</title>
        <link>http://www.cmjournal.org</link>
        <description>The latest research articles published by Chinese Medicine</description>
        <dc:date>2012-01-21T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.cmjournal.org/content/7/1/1" />
                                <rdf:li rdf:resource="http://www.cmjournal.org/content/6/1/42" />
                                <rdf:li rdf:resource="http://www.cmjournal.org/content/6/1/41" />
                                <rdf:li rdf:resource="http://www.cmjournal.org/content/6/1/40" />
                                <rdf:li rdf:resource="http://www.cmjournal.org/content/6/1/39" />
                                <rdf:li rdf:resource="http://www.cmjournal.org/content/6/1/38" />
                                <rdf:li rdf:resource="http://www.cmjournal.org/content/6/1/37" />
                                <rdf:li rdf:resource="http://www.cmjournal.org/content/6/1/36" />
                                <rdf:li rdf:resource="http://www.cmjournal.org/content/6/1/35" />
                                <rdf:li rdf:resource="http://www.cmjournal.org/content/6/1/34" />
                            </rdf:Seq>
        </items>
                 <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.cmjournal.org/content/7/1/1">
        <title>Baicalein antagonizes rotenone-induced apoptosis in dopaminergic SH-SY5Y cells related to Parkinsonism</title>
        <description>Background:
Two active compounds, baicalein and its glycoside baicalin were found in the dried root of Scutellaria baicalensis Georgi, and reported to be neuroprotective in vitro and in vivo. This study aims to evaluate the protective effects of baicalein on the rotenone-induced apoptosis in dopaminergic SH-SY5Y cells related to parkinsonism.
Methods:
Cell viability and cytotoxicity were determined by MTT assay. The degree of nuclear apoptosis was evaluated with a fluorescent DNA-binding probe Hoechst 33258. The production of reactive oxidative species (ROS) and loss of mitochondrial membrane potential (Deltapsim) were determined by fluorescent staining with DCFH-DA and Rhodanmine 123, respectively. The expression of Bax, Bcl-2, cleaved caspase-3 and phosphorylated ERK1/2 was determined by the Western blots.
Results:
Baicalein significantly increased viability and decreased rotenone-induced death of SH-SY5Y cells in a dose-dependent manner. Pre- and subsequent co-treatment with baicalein preserved the cell morphology and attenuated the nuclear apoptotic characteristics triggered by rotenone. Baicalein antagonized rotenone-induced overproduction of ROS, loss of Deltapsim, the increased expression of Bax, cleaved caspase-3 and phosphorylated ERK1/2 and the decreased expression of Bcl-2.
Conclusion:
The antioxidative effect, mitochondrial protection and modulation of anti-and pro-apoptotic proteins are related to the neuroprotective effects of baicalein against rotenone induced cell death in SH-SY5Y cells.</description>
        <link>http://www.cmjournal.org/content/7/1/1</link>
                <dc:creator>Ju-Xian Song</dc:creator>
                <dc:creator>Mandy Yuen-Man Choi</dc:creator>
                <dc:creator>Kavin Chun-Kit Wong</dc:creator>
                <dc:creator>Winkie Wing-Yan Chung</dc:creator>
                <dc:creator>Stephen Cho-Wing Sze</dc:creator>
                <dc:creator>Tzi-Bun Ng</dc:creator>
                <dc:creator>Kalin Yan-Bo Zhang</dc:creator>
                <dc:source>Chinese Medicine 2012, null:1</dc:source>
        <dc:date>2012-01-21T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1749-8546-7-1</dc:identifier>
                                <prism:require>/content/figures/1749-8546-7-1-toc.gif</prism:require>
                <prism:publicationName>Chinese Medicine</prism:publicationName>
        <prism:issn>1749-8546</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>1</prism:startingPage>
        <prism:publicationDate>2012-01-21T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cmjournal.org/content/6/1/42">
        <title>Forensically informative nucleotide sequencing (FINS) for the authentication of Chinese medicinal materials</title>
        <description>Chinese medicinal materials may be authenticated by molecular identification. As a definitive approach to molecular identification of medicinal materials, forensically informative nucleotide sequencing (FINS) comprises four steps, namely (1) DNA extraction from biological samples, (2) selection and amplification of a specific DNA fragment, (3) determination of the sequence of the amplified DNA fragment and (4) cladistic analysis of the sample DNA sequence against a DNA database. Success of the FINS identification depends on the selection of DNA region and reference species. This article describes the techniques and applications of FINS for authenticating Chinese medicinal materials.</description>
        <link>http://www.cmjournal.org/content/6/1/42</link>
                <dc:creator>Ming Li</dc:creator>
                <dc:creator>Kalin Yan-Bo Zhang</dc:creator>
                <dc:creator>Paul Pui-Hay But</dc:creator>
                <dc:creator>Pang-Chui Shaw</dc:creator>
                <dc:source>Chinese Medicine 2011, null:42</dc:source>
        <dc:date>2011-12-09T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1749-8546-6-42</dc:identifier>
                                <prism:require>/content/figures/1749-8546-6-42-toc.gif</prism:require>
                <prism:publicationName>Chinese Medicine</prism:publicationName>
        <prism:issn>1749-8546</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>42</prism:startingPage>
        <prism:publicationDate>2011-12-09T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cmjournal.org/content/6/1/41">
        <title>Intestinal absorbability of three Radix Puerariae isoflavones including daidzein, daidzin and puerarin</title>
        <description>Background:
Radix Puerariae (Gegen) contains abundant isoflavones in the forms of glycosides and aglycones, such as daidzein, daidzin and puerarin. This study aims to investigate the intestinal absorbability and mechanism of these three structurally related isoflavones.
Methods:
The bi-directional transport of these three isoflavones in Caco-2 monolayer model was performed to evaluate their absorbability and involvement of transporters in Transwell. In vitro incubation of daidzin and puerarin with rat intestinal microvilli preparation was conducted to estimate their potential form of absorption in vivo.
Results:
Daidzein demonstrated passive diffusion transport while puerarin did not. Daidzin showed basolateral-to-apical transport and the absorption extent could be reduced by 50% in the presence of MK571, a multidrug resistance-associated protein inhibitor (MRP). The in vitro incubation study of daidzin and puerarin indicated that daidzin was hydrolyzed to daidzein whereas puerarin remained unchanged.
Conclusion:
While daidzein was transported more efficiently, puerarin was resistant to intestinal hydrolysis and inefficiently transported across intestinal epithelium. Daidzin demonstrated a low intestinal absorbability due to a significant efflux transport mediated by MRPs. Daidzin was likely to be hydrolyzed by intestinal microvilli and subsequently released daidzein for intestinal absorption.</description>
        <link>http://www.cmjournal.org/content/6/1/41</link>
                <dc:creator>Li Zhang</dc:creator>
                <dc:creator>Antony Siu</dc:creator>
                <dc:creator>Ge Lin</dc:creator>
                <dc:creator>Zhong Zuo</dc:creator>
                <dc:source>Chinese Medicine 2011, null:41</dc:source>
        <dc:date>2011-11-23T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1749-8546-6-41</dc:identifier>
                                <prism:require>/content/figures/1749-8546-6-41-toc.gif</prism:require>
                <prism:publicationName>Chinese Medicine</prism:publicationName>
        <prism:issn>1749-8546</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>41</prism:startingPage>
        <prism:publicationDate>2011-11-23T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cmjournal.org/content/6/1/40">
        <title>Effects of Erxian decoction, a Chinese medicinal formulation, on serum lipid profile in a rat model of menopause</title>
        <description>Background:
The prevalence and risk of cardiovascular disease increase after menopause in correlation with the progression of abnormality in the serum lipid profile and the deprivation of estrogen. Erxian decoction (EXD), a Chinese medicinal formulation for treating menopausal syndrome, stimulates ovarian estrogen biosynthesis. This study investigates whether EXD improves the serum lipid profile in a menopausal rat model.
Methods:
Twenty-month-old female Sprague Dawley rats were treated with EXD and its constituent fractions. Premarin was administered for comparison. After eight weeks of treatment, rats were sacrificed and the serum levels of total cholesterol, triglyceride, high-density-lipoprotein cholesterol and low-density-lipoprotein cholesterol were determined. The hepatic protein levels of 3-hydroxy-3-methyl-glutaryl-CoA reductase and low-density-lipoprotein receptor were assessed with Western blot.
Results:
The serum levels of total cholesterol and low-density-lipoprotein cholesterol were significantly lower in the EXD-treated group than in the constituent fractions of EXD or premarin groups. However, the serum levels of triglyceride and high-density-lipoprotein cholesterol were not significantly different from the control groups. Results from Western blot suggest that EXD significantly down-regulated the protein level of 3-hydroxy-3-methyl-glutaryl-CoA reductase and up-regulated low-density-lipoprotein receptor. Conclusion EXD improves serum lipid profile in a menopausal rat model through the suppression of the serum levels of total cholesterol and low-density-lipoprotein cholesterol, possibly through the down-regulation of the 3-hydroxy-3-methyl-glutaryl-CoA and up-regulation of the low-density-lipoprotein receptor.</description>
        <link>http://www.cmjournal.org/content/6/1/40</link>
                <dc:creator>Stephen Sze</dc:creator>
                <dc:creator>Ho-Pan Cheung</dc:creator>
                <dc:creator>Tzi-Bun Ng</dc:creator>
                <dc:creator>Zhang-Jing Zhang</dc:creator>
                <dc:creator>Kam-Lok Wong</dc:creator>
                <dc:creator>Hei-Kiu Wong</dc:creator>
                <dc:creator>Yong-Mei Hu</dc:creator>
                <dc:creator>Christine Yow</dc:creator>
                <dc:creator>Yao Tong</dc:creator>
                <dc:source>Chinese Medicine 2011, null:40</dc:source>
        <dc:date>2011-11-02T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1749-8546-6-40</dc:identifier>
                                <prism:require>/content/figures/1749-8546-6-40-toc.gif</prism:require>
                <prism:publicationName>Chinese Medicine</prism:publicationName>
        <prism:issn>1749-8546</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>40</prism:startingPage>
        <prism:publicationDate>2011-11-02T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cmjournal.org/content/6/1/39">
        <title>Cytotoxic and apoptotic effects of six herbal plants against the human hepatocarcinoma (HepG2) cell line</title>
        <description>Background:
Six plants from Thailand were evaluated for their cytotoxicity and apoptosis induction in human hepatocarcinoma (HepG2) as compared to normal African green monkey kidney epithelial cell lines.
Methods:
Ethanol-water crude extracts of the six plants were tested with neutral red assay for their cytotoxicity after 24 hours of exposure to the cells. Apoptotic induction was tested in the HepG2 cells with diamidino-2-phenylindole staining. DNA fragmentation, indicative of apoptosis, was analyzed with agarose gel electrophoresis. Alkylation, indicative of DNA damage, was also evaluated in vitro by 4-(4&apos;-nitrobenzyl) pyridine assay.
Results:
The extract of Pinus kesiya showed the highest selectivity (selectivity index = 9.6) and potent cytotoxicity in the HepG2 cell line, with an IC50 value of 52.0 &#177; 5.8 &#956;g/ml (mean &#177; standard deviation). Extract of Catimbium speciosum exerted cytotoxicity with an IC50 value of 55.7 &#177; 8.1 &#956;g/ml. Crude extracts from Glochidion daltonii, Cladogynos orientalis, Acorus tatarinowii and Amomum villosum exhibited cytotoxicity with IC50 values ranging 100-500 &#956;g/ml. All crude extracts showed different alkylating abilities in vitro. Extracts of P. kesiya, C. speciosum and C. orientalis caused nuclei morphological changes and DNA laddering.
Conclusion:
The extracts of C. speciosum, C. orientalis and P. kesiya induced apoptosis. Among the three plants, P. kesiya possessed the most robust anticancer activity, with specific selectivity against HepG2 cells.</description>
        <link>http://www.cmjournal.org/content/6/1/39</link>
                <dc:creator>Sasipawan Machana</dc:creator>
                <dc:creator>Natthida Weerapreeyakul</dc:creator>
                <dc:creator>Sahapat Barusrux</dc:creator>
                <dc:creator>Apiyada Nonpunya</dc:creator>
                <dc:creator>Bungorn Sripanidkulchai</dc:creator>
                <dc:creator>Thaweesak Thitimetharoch</dc:creator>
                <dc:source>Chinese Medicine 2011, null:39</dc:source>
        <dc:date>2011-10-31T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1749-8546-6-39</dc:identifier>
                                <prism:require>/content/figures/1749-8546-6-39-toc.gif</prism:require>
                <prism:publicationName>Chinese Medicine</prism:publicationName>
        <prism:issn>1749-8546</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>39</prism:startingPage>
        <prism:publicationDate>2011-10-31T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cmjournal.org/content/6/1/38">
        <title>Antioxidant properties of lutein contribute to the protection against lipopolysaccharide-induced uveitis in mice</title>
        <description>Background:
Lutein is an important eye-protective nutrient. This study investigates the protective effects and mechanisms of lutein on lipopolysaccharides (LPS)-induced uveitis in mice.
Methods:
Lutein, suspended in drinking water at a final concentration of 12.5 and 25 mg/mL, was administered to mice at 0.1 mL/10 g body weight for five consecutive days. Control and model group received drinking water only. Uveitis was induced by injecting LPS (100 mg per mouse) into the footpad in the model and lutein groups on day 5 after the last drug administration. Eyes of the mice were collected 24 hours after the LPS injection for the detection of indicators using commercial kits and reverse transcription-polymerase chain reaction.
Results:
LPS-induced uveitis was confirmed by significant pathological damage and increased the nitric oxide level in eye tissue of BALB/C mice 24 hours after the footpad injection. The elevated nitric oxide level was significantly reduced by oral administration of lutein (125 and 500 mg/kg/d for five days) before LPS injection. Moreover, lutein decreased the malondialdehyde content, increased the oxygen radical absorbance capacity level, glutathione, the vitamin C contents and total superoxide dismutase (SOD) and glutathione peroxidase (GPx) activities. Lutein further increased expressions of copper-zinc SOD, manganese SOD and GPx mRNA. Conclusion The antioxidant properties of lutein contribute to the protection against LPS-induced uveitis, partially through the intervention of inflammation process.</description>
        <link>http://www.cmjournal.org/content/6/1/38</link>
                <dc:creator>Rong-Rong He</dc:creator>
                <dc:creator>Bun Tsoi</dc:creator>
                <dc:creator>Fang Lan</dc:creator>
                <dc:creator>Nan Yao</dc:creator>
                <dc:creator>Xin-Sheng Yao</dc:creator>
                <dc:creator>Hiroshi Kurihara</dc:creator>
                <dc:source>Chinese Medicine 2011, null:38</dc:source>
        <dc:date>2011-10-31T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1749-8546-6-38</dc:identifier>
                                <prism:require>/content/figures/1749-8546-6-38-toc.gif</prism:require>
                <prism:publicationName>Chinese Medicine</prism:publicationName>
        <prism:issn>1749-8546</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>38</prism:startingPage>
        <prism:publicationDate>2011-10-31T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cmjournal.org/content/6/1/37">
        <title>Comparative study on saponin fractions from Panax notoginseng inhibiting inflammation-induced endothelial adhesion molecule expression and monocyte adhesion</title>
        <description>Background:
Panax notoginseng is commonly used for the treatment of cardiovascular diseases in China. The present study investigates the effects of three different saponin fractions (ie total saponins, PNS; protopanaxadiol-type saponin, PDS; and protopanaxatriol-type saponin, PTS) and two major individual ingredients (ie ginsenoside Rg1 and Rb1) from P. notoginseng on the endothelial inflammatory response in vitro and in vivo.
Methods:
Recombinant human tumor necrosis factor-&#945; (TNF-&#945;) was added to the culture medium of human coronary artery endothelial cells (HCAECs) to induce an inflammatory response. A cell adhesion assay was used to determine the effect of the P. notoginseng saponin fractions on endothelial-monocyte interaction. The cell adhesion molecule (CAMs) expression, including ICAM-1 and VCAM-1, in the protein level on the surface of endothelial cells were measured by cellular ELISA. CAMs expression in mRNA level was also assayed by qRT-PCR in the HCAECs and the aorta of rat fed with high cholesterol diet (HCD). Western blotting was used to detect effect of the saponin fractions on CAMs protein expression in HCAECs. In addition, nuclear translocation of p65, a surrogate marker for NF-&#954;B activation, was measured by immunostaining.
Results:
Three saponin fractions and two individual ginsenosides exhibited the inhibitory effects on monocyte adhesion on TNF-&#945;-activated HCAECs and expression of ICAM-1 and VCAM-1 at both mRNA and protein levels in vitro. The saponin fractions exhibited a similar trend of the inhibitory effects on the mRNA expression of CAMs in the aorta of HCD-fed rat in vivo. These inhibitory effect of saponin fractions maybe attribute partially to the suppression of the TNF-&#945;-induced NF-&#954;B activation.
Conclusion:
Our data demonstrate that saponin fractions (ie PNS, PDS and PTS) and major individual ginsenosides (ie Rg1 and Rb1) have potential anti-atherogenic effects. Among the tested saponin fractions, PDS is the most potent saponin fraction against TNF-&#945;-induced monocyte adhesion as well as the expression of adhesion molecules in vitro and in vivo.</description>
        <link>http://www.cmjournal.org/content/6/1/37</link>
                <dc:creator>Nan Wang</dc:creator>
                <dc:creator>Jian-Bo Wan</dc:creator>
                <dc:creator>Shun-Wan Chan</dc:creator>
                <dc:creator>Yan-Hui Deng</dc:creator>
                <dc:creator>Nan Yu</dc:creator>
                <dc:creator>Qing-Wen Zhang</dc:creator>
                <dc:creator>Yi-Tao Wang</dc:creator>
                <dc:creator>Simon Ming-Yuen Lee</dc:creator>
                <dc:source>Chinese Medicine 2011, null:37</dc:source>
        <dc:date>2011-10-13T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1749-8546-6-37</dc:identifier>
                                <prism:require>/content/figures/1749-8546-6-37-toc.gif</prism:require>
                <prism:publicationName>Chinese Medicine</prism:publicationName>
        <prism:issn>1749-8546</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>37</prism:startingPage>
        <prism:publicationDate>2011-10-13T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cmjournal.org/content/6/1/36">
        <title>Boswellic acids extract attenuates pulmonary fibrosis induced by bleomycin and oxidative stress from gamma irradiation in rats</title>
        <description>Background:
Interstitial pulmonary fibrosis is characterized by an altered cellular composition of the alveolar region with excessive deposition of collagen. Lung inflammation is also common in pulmonary fibrosis. This study aims to test the inhibition of 5-lipooxygenase (5-LOX) by boswellic acid (BA) extract in an experimental model of pulmonary fibrosis using bleomycin (BL).
Methods:
Boswellic acid extract (1 g/kg) was force-fed to rats seven days prior to administration of BL or gamma irradiation or both. BL (0.15 U/rat) in 25 &#956;l of 0.9% normal saline (NS) or 0.9% NS alone was administered intratracheally. Rats were exposed to two fractionated doses of gamma irradiation (0.5 Gy/dose/week) with a gamma cell-40 (Cesium-137 irradiation units, Canada) during the last two weeks of the experiment. BA was administered during BL or irradiation treatment or both. After the animals were sacrificed, bronchoalveolar lavage was performed; lungs were weighed and processed separately for biochemical and histological studies.
Results:
In rats treated with BL, levels of transforming growth factor-&#946;1 (TGF-&#946;1) and tumor necrosis factor-&#945; (TNF-&#945;) were significantly elevated (P = 0.05 and P = 0.005). Hydroxyproline was highly and extensively expressed. Immunoreactive compounds were abundantly expressed, represented in the levels of macrophages infiltrate, accumulation of eosinophils and neutrophils in the lung as well as the aggregation of fibroblasts in the fibrotic area. The levels of lipoxygenase enzyme activity were significantly increased (P = 0.005). Antioxidant activities measured in BL-treated rats deteriorated, coupled with the elevation of both levels of plasma lipid peroxide (LP) content and bronchoalveolar lavage lactate dehydrogenase activity. BA-treated rats had reduced number of macrophages, (P = 0.01), neutrophils in bronchoalveolar lavage (P = 0.01) and protein (P = 0.0001). Moreover, the hydroxyproline content was significantly lowered in BA-treated rats (P = 0.005). BA extract inhibited the TGF-&#223; induced fibrosis (P = 0.01) and 5-LOX activity levels (P = 0.005).Histologically, BA reduced the number of infiltrating cells, ameliorated the destruction of lung architecture and attenuated lung fibrosis.
Conclusion:
BA attenuates the BL-induced injury response in rats, such as collagen accumulation, airway dysfunction and injury. This study suggests that the blocking of 5-LOX may prevent the progression of fibrosis.</description>
        <link>http://www.cmjournal.org/content/6/1/36</link>
                <dc:creator>Eman Ali</dc:creator>
                <dc:creator>Somaya Mansour</dc:creator>
                <dc:source>Chinese Medicine 2011, null:36</dc:source>
        <dc:date>2011-09-30T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1749-8546-6-36</dc:identifier>
                                <prism:require>/content/figures/1749-8546-6-36-toc.gif</prism:require>
                <prism:publicationName>Chinese Medicine</prism:publicationName>
        <prism:issn>1749-8546</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>36</prism:startingPage>
        <prism:publicationDate>2011-09-30T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cmjournal.org/content/6/1/35">
        <title>Chinese herbal extracts of Rubia cordifolia and Dianthus superbus suppress IgE production and prevent peanut-induced anaphylaxis</title>
        <description>Background:
Peanut allergy is characterized by increased levels of peanut-specific IgE in the serum of most patients. Thus, the most logical therapy would be to inhibit the IgE production by committed B-cells. This study aims to investigate the unreported anti-IgE effects of Chinese herbal extracts of Rubia cordifolia (Qiancao) and Dianthus superbus (Qumai).
Methods:
Seventy herbal extracts were tested for their ability to reduce IgE secretion by a human B-cell line. Those with the lowest inhibitory concentration 50 (IC50) values were tested in a mouse model of peanut-anaphylaxis. Anaphylactic scores, body temperature, plasma histamine and peanut-specific-immunoglobulins were determined.
Results:
Rubia cordifolia and Dianthus superbus inhibited the in vitro IgE production by a human B-cell line in a dose-dependent manner and the in vivo IgE production in a murine model of peanut allergy without affecting peanut-specific-IgG1 levels. After challenge, all mice in the sham groups developed anaphylactic reactions and increased plasma histamine levels. The extract-treated mice demonstrated significantly reduced peanut-triggered anaphylactic reactions and plasma histamine levels.
Conclusion:
The extracts of Rubia cordifolia and Dianthus superbus inhibited the IgE production in vivo and in vitro as well as reduced anaphylactic reactions in peanut-allergic mice, suggesting potentials for allergy treatments.</description>
        <link>http://www.cmjournal.org/content/6/1/35</link>
                <dc:creator>Ivan Lopez Exposito</dc:creator>
                <dc:creator>Alexandra Castillo</dc:creator>
                <dc:creator>Nan Yang</dc:creator>
                <dc:creator>Banghao Liang</dc:creator>
                <dc:creator>Xiu-Min Li</dc:creator>
                <dc:source>Chinese Medicine 2011, null:35</dc:source>
        <dc:date>2011-09-30T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1749-8546-6-35</dc:identifier>
                                <prism:require>/content/figures/1749-8546-6-35-toc.gif</prism:require>
                <prism:publicationName>Chinese Medicine</prism:publicationName>
        <prism:issn>1749-8546</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>35</prism:startingPage>
        <prism:publicationDate>2011-09-30T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cmjournal.org/content/6/1/34">
        <title>Molecular identification of Lodoicea maldivica (coco de mer) seeds</title>
        <description>Background:
The edible endosperm of Lodoicea maldivica with the common name of coco de mer is used in Chinese medicine for treating cough. Native to Seychelles, Lodoicea maldivica seeds have commanded high prices for centuries due to its scarcity. This study aims to develop a molecular identification method for the authentication of Lodoicea maldivica seeds.
Methods:
DNA was extracted from the sample. Two polymerase chain reaction (PCR) systems were developed to amplify a region of the chloroplast DNA and the nuclear phosphoribulokinase (PRK) region specific to Lodoicea maldivica respectively. DNA sequence of a sample was determined and compared with that of the Lodoicea maldivica reference material.
Results:
The PRK gene of Lodoicea maldivica was successfully amplified and sequenced for identification.
Conclusion:
A new molecular method for the identification of Lodoicea maldivica seeds in fresh, frozen or dried forms was developed.</description>
        <link>http://www.cmjournal.org/content/6/1/34</link>
                <dc:creator>Chun-yin Mak</dc:creator>
                <dc:creator>Chuen-shing Mok</dc:creator>
                <dc:source>Chinese Medicine 2011, null:34</dc:source>
        <dc:date>2011-09-30T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1749-8546-6-34</dc:identifier>
                                <prism:require>/content/figures/1749-8546-6-34-toc.gif</prism:require>
                <prism:publicationName>Chinese Medicine</prism:publicationName>
        <prism:issn>1749-8546</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>34</prism:startingPage>
        <prism:publicationDate>2011-09-30T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>

